Menu
June 30, 2021

Risks of Myocarditis: Are COVID Vaccines in our Children’s Best Interest?

Overview

Today’s article contains updates on FDA Emergency Use Authorizations (EUAs) for experimental COVID vaccines, pediatric vaccine clinical trials, reports on myocarditis/pericarditis data in 12 to 29-year-olds presented at the Advisory Committee on Immunization Practices (ACIP) meeting, accounts of teens and young adults suffering complications of heart inflammation, most recent VAERS data on these heart conditions, details of VAERS reports of adverse events and their outcomes, serious adverse events, and deaths occurring in 12 to 17-year-olds following these COVID shots, continued meetings and assurances of vaccine safety and joint statement from our federal public health agencies, officials, and organizations, and more.

 

By Dawn Amittai

We have been hearing a great deal of emphasis in the news lately about the inordinate push to authorize COVID vaccines for our children. We have simultaneously been hearing increasing numbers of reports of life-threatening heart inflammation — myocarditis and pericarditis — occurring in our teens and young adults.

Robert F. Kennedy Jr., chairman of Children’s Health Defense, makes a crucial point to take into account prior to even considering administering these vaccines to children. “Unlike other drugs, vaccines are given to healthy individuals. We therefore should be far less tolerant of risk.” He aptly concludes, “We need to be especially attentive to risks in children about whom there is almost no relevant safety information. Children, after all, have almost no risk from the disease [COVID] and so any risk from the vaccine is unacceptable.”

With that said, we present brief updates around this theme, including recent meetings of our various federal public health agencies — data presented by their officials, their conclusions, and related public health policy decisions implemented to date.

Experimental COVID Vaccines: Emergency Use Authorization (EUA) Updates

In our last article, we discussed the May 10th FDA update, that expanded the Emergency Use Authorization (EUA) of Pfizer’s vaccine from 16 years of age and up to include adolescents 12 through 15. As we have repeatedly asserted, children have a statistically zero risk of dying from COVID-19 illness… is it really in their best interest to give them a vaccine — now linked to a higher-than-expected rate of heart inflammation — which is not really necessary for them?

Currently, Pfizer’s vaccine is authorized for use in those 12 years of age and over; Moderna’s for 18 and up, with a current request to FDA to authorize it for those 12 years of age and older; J&J’s vaccine is authorized in those 18 and up. There are ongoing clinical trials of all three of these experimental shots in children, with plans to test them in infants as young as 6 months of age.  On June 10th, the members of the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) met to discuss the areas in which data will be needed for authorization and/or licensure of these vaccines for use in pediatric populations. Following the meeting, FDA advisor Dr. Paul Offit summarized, “I certainly think we would have a vaccine by early next year, and hopefully we’ll have a vaccine for the 6-to-12-year-old by the end of the year.”

After reviewing COVID-19 weekly vaccine safety data the last week of May, the Advisory Committee on Immunization Practices (ACIP) called an emergency meeting for June 18, to discuss cases of myocarditis/pericarditis following mRNA COVID-19 vaccination, because “… data from VAERS show that in the 30-day window following dose 2 mRNA COVID-19 vaccination, there was a higher number of observed than expected myocarditis/pericarditis cases in 16–24-year-olds.” However, this “emergency meeting” was rescheduled “… due to the observation of the Juneteenth National Independence Day holiday” and was instead added to the routine ACIP meeting scheduled for June 23-25.

Preliminary Myocarditis/Pericarditis Data from VAERS Through June 11, 2021, as Presented at ACIP Meeting June 23, 2021

At the June 23rd ACIP meeting, preliminary VAERS data on the expected versus the observed number of cases of myocarditis/pericarditis following mRNA shots were presented by Tom Shimabukuro, MD, MPH, MBA (see screen shot).

Looking at the expected numbers of cases of myocarditis/pericarditis as compared to the actual number of cases observed within the 7 day period after a second dose of an experimental mRNA vaccine, demonstrates that the risk of developing this potentially life-threatening condition is significantly higher than expected in these age groups:

  • For those 12-17 years of age, the risk of developing myocarditis/pericarditis within 7 days of receiving the second dose is 32 times greater than expected for males and 9.5 times greater for females.
  • For those 18-24 years of age, the risk of developing myocarditis/pericarditis within 7 days of receiving the second dose is 27 times greater than expected for males and 3.8 times greater for females.
  • For those 25-29 years of age, the risk of developing myocarditis/pericarditis within 7 days of receiving the second dose is 8 times greater than expected for males and 1.4 times greater for females.

 

June 23rd ACIP Meeting Concludes “Benefits of COVID Vaccination Outweigh Risks of Myocarditis/Pericarditis”

Vaccine advisors agreed that there is a “likely association between the mRNA COVID-19 vaccines and rare cases of heart inflammation in adolescents and young adults” but that “most cases are mild, and individuals recover often on their own or with minimal treatment.” Sadly, this is not what we are hearing from those teens and young adults who have experienced this life-threatening and potentially permanently disabling condition themselves… here are a few of their stories.

Previously a healthy athlete, 18-year-old Isaiah Harris (see photo) from Springdale, Arkansas developed endocarditis, suffering a heart attack 48 hours after a second dose of Pfizer’s COVID vaccine. Isaiah said he “would rather get COVID than have a heart attack,” and his father concluded, “Isaiah would have been better off to have COVID and be healthy than have a possible life-long issue with his heart, and now another possible heart attack if he overextends himself in the next three to six months.”

Alex Franks (see photo) was a healthy 17-year-old high school junior from Pittsburg who never had any medical issues until just two days after a second dose of Pfizer’s experimental COVID shot. “It was the middle of the night. I was walking upstairs from the basement when I got a sudden constricting feeling in my chest,” Alex recounted. His parents immediately rushed him to the hospital. His mother Karen recalls, “That’s when things became eye-opening for us because it became much more serious very, very fast.” That is when doctors discovered Alex Franks had myocarditis, inflammation around his heart.

What about the untimely deaths of 19-year-old Simone Scott and 13-year-old Jacob Clynick  who both lost their lives due to complications related to this condition?

13-year-old Jacob Clynick (see photo) had very recently completed 8th grade and was looking forward to starting high school and joining the band. Instead, he died three days after his second Pfizer shot. According to his aunt, Tami Burages, “A week ago today my brother’s 13-year-old son had his second COVID shot. Less than 3 days later he died. The initial autopsy results were that his heart was enlarged and there was some fluid surrounding it. He had no known health problems. Was on no medications.” According to his obituary, he “…was a student at Zilwaukee Elementary. Jacob was a faithful and active member of the church youth group for many years. He loved gaming and loved Pokémon. Jacob was known for his jokes and had a meme for every occasion. But, what he really loved most was his family.”

According to her grieving parents, 19-year-old Simone Scott (see photo), who died after a heart transplant post-COVID shots, was healthy and in her second semester at Northwestern. Simone had received her second Moderna jab May 1st, and made a recent surprise visit home for Mother’s Day. Her mother, Valerie Kraimer remembers, “I did notice that she was kind of stuffy, so her voice wasn’t exactly the same.” Simone returned to school on May 11, but only got worse even after a visit to the doctor; all tests were negative including a COVID-19 test.

Her mother recalled, “Simone texted her father and said, ‘Dad, I feel so dizzy. I cannot get out of bed’ and that’s when everything really started from there.” Her father called Northwestern campus police to arrange for someone to check in on her, and “We learned that a doctor had to jump on her chest and give her CPR because she was that bad, and then the whole cascade of events happened. They had to intubate her and realized that she was in heart failure,” her mother said. Doctors believe she developed myocarditis after her second dose of the Moderna jab. After multiple interventions including a heart transplant, 19-year-old Simone Scott died on June 11th… scarcely over a month after she had flown home for Mother’s Day.

Apparently, vaccine advisors came to the conclusion that “the benefits of vaccination still clearly outweigh the risks.” Looking at the CDC’s estimated fatality rates for COVID-19 illness in these age groups (see table), it is difficult to ascertain how these “vaccine advisors” arrived at this conclusion. What vaccine benefits are they referring to for our teens and young adults? Even Dr. Fauci acknowledged we do not know if these shots prevent COVID infection or the spread of the virus to others — or if they do, how long this limited immunity might last. So, how is it possible that these so-called “vaccine benefits” could outweigh the very real risks of these experimental mRNA shots — even if only looking at the increased risk of developing myocarditis/pericarditis — in a population with a statistically zero risk of death if they ever experience COVID-19 illness?

FDA Adds Heart Inflammation Warning to Pfizer and Moderna Vaccines

Following the June 23rd ACIP meeting, the FDA announced it will “…add a warning to the COVID vaccines produced by Pfizer and Moderna about rare cases of heart inflammation in adolescents and young adults.” A joint statement was issued from the leaders of more than a dozen of our public health agencies and organizations — including the US Department of Health and Human Services, CDC, American Academy of Pediatrics, American Heart Association and more — which concluded, “The vaccines are safe and effective, and they prevent COVID-19 illness. They will help protect you and your family and keep your community safe. We strongly encourage everyone age 12 and older who are eligible to receive the vaccine under Emergency Use Authorization to get vaccinated, as the benefits of vaccination far outweigh any harm…” Is it any wonder that so many Americans have lost trust in our federal public health agencies?

VAERS Data on Adverse Events Occurring in 12 to 17-Year-Olds by June 18, 2021

Following the FDA’s extension of Pfizer’s COVID shot Emergency Use Authorization (EUA) to those 12 years of age and above, we searched the VAERS database for cases of myocarditis/pericarditis, adverse events and their outcomes (e.g., hospitalizations, ER visits, permanent disabilities, etc.), serious adverse events, and death reports of primarily 12 to 17-year-olds through June 18th. The results are presented here.

 

Tracking Myocarditis/Pericarditis Following COVID Vaccines Reported by VAERS by June 18, 2021

Searching VAERS for cases of myocarditis and pericarditis, we found a total of 1,342 reports in all age groups. The two highest age groups were those 12 to 17-years-of-age and 17 to 44-years-of-age: 171 reports (13%) occurred in those aged 12 to 17, and 803 cases (60%) occurred in those 17-44 years of age (see VAERS report).

As always, we should keep in mind the number of cases reported to VAERS represents only 1% of all the actual vaccine adverse events and 1-13% of serious adverse events/deaths; thus, the actual number of COVID vaccine recipients experiencing myocarditis/pericarditis could even be as high as 134,200.

Event Outcomes for 11,856* AEs Occurring in 12 to 17-Year-Olds Following COVID Vaccines by June 18th

We tracked the outcomes of adverse events (AEs) which occurred in 12 to 17-year-olds entered in VAERS by June 18th. Findings reveal about 1,276 (11%) teens and adolescents people reporting AEs presented to an emergency room, 573 (5%) were hospitalized, 120 (1%) experienced life-threatening events, 26 (.22%) resulted in permanent disability (many cases are still unresolved at the time of this report, so this number is likely grossly understated), and about 9 (.08%) of the reports resulted in death (see VAERS report).

*Because some cases have multiple vaccinations and symptoms, a single case can account for multiple entries in this table; this is the reason why this report from VAERS shows the total count is greater than the actual number of cases/events and the total percentage is greater than 100.

 582* SERIOUS AEs Occurring in 12 to 17-Year-Olds Following COVID Vaccines by June 18th

The FDA defines serious adverse events as “any undesirable experience associated with the use of a medical product in a patient” which is deemed life-threatening, results in death, hospitalization (initial or prolonged), emergency room visit(s), disability or permanent damage, congenital anomaly/birth defect, or requires intervention to prevent permanent impairment or damage. This VAERS report shows that there have been 582 adverse events in 6 to 17-year-olds deemed serious by June 18, 2021 (see VAERS report).

*Because some cases have multiple vaccinations and symptoms, a single case can account for multiple entries in this table; this is the reason why this report from VAERS shows the total count is greater than the actual number of cases/events and the total percentage is greater than 100.

Tracking Reported Deaths Following COVID Shots in 12 to 17-Year-Olds

Next, we explored VAERS for cases of 12 to 17-year-olds who died following one of these shots; reported cases through June 18th include:

  • VAERS ID 1187918-1: A 15-year-old female from New Hampshire suffered a fatal cardiac arrest following a Moderna vaccine. [Note: there is no mention of why she received the Moderna vaccine which is not authorized for those under 18 years of age, unless perhaps she was participating in a clinical trial].
  • VAERS ID 1199455-1: A 17-year-old female from Wisconsin — “Patient reported difficulty breathing and cheat pain; suffered cardiac arrest and death” 8 days after a Pfizer shot.
  • VAERS ID 1225942-1: “Patient was a 16 yr. female [from Wisconsin] who received Pfizer vaccine 3/19/21 at vaccine clinic and presented with ongoing CPR to the ED 3/28/21 after cardiac arrest at home. Patient placed on ECMO, and imaging revealed bilateral large pulmonary embolism as likely etiology of arrest. Risk factors included oral contraceptive use. Labs have since confirmed absence of Factor V Leiden or prothrombin gene mutation. Patient declared dead by neurologic criteria 3/30/21.”
  • VAERS ID 1242573-1: 15-year-old male from Colorado died from cardiac failure, “Vaccinated with Pfizer/BioNTech, died 04/20/2021, 2 days after vaccination.”
  • VAERS ID 1243487-1: 17-year-old male from Michigan with no prior history of mental illness; “Patient committed suicide with a firearm” 8 days after one Pfizer shot.
  • VAERS ID 1307657-1: 17-year-old male from Ohio with no mental health history, “Complete suicide” 4 days after a second Pfizer shot.
  • VAERS ID 1353097-1: 15-year-old female died from cardiac arrest after a second Moderna shot; “…The patient died on an unknown date. The reported cause of death was cardiac arrest. It is unknown if an autopsy was performed. At the time of death, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (15-year-old female received vaccine) …” NOTE: This VAERS ID report is currently “not found” in the VAERS database as of June 26, 2021.
  • VAERS ID 1382906-1: 15-year-old male from California suffered “Unexplained death within 48 hours” of second Pfizer shot.
  • VAERS ID 1383620-1: 15-year-old male from California, “Sudden death one day after receiving second dose of Pfizer COVID Vaccine (6/6/21). Found dead.” NOTE: This VAERS ID report is currently “not found” in the VAERS database as of June 26, 2021.
  • VAERS ID 1386841-1: 4 days after a Pfizer shot, a 16-year-old male from Georgia experienced “Prodrome of headache and gastric upset over 2 days following second dose. Then felt fine. Found the following day dead in bed. Autopsy pending.”

 

We have seen the numbers of cases of myocarditis and pericarditis occurring in 12 to 24-year-olds within 7 days of a second dose of an experimental mRNA vaccine — particularly males — presented by Dr. Shimabukuro at the recent ACIP meeting. When compared to the would-be-expected numbers, they appear truly alarming. Is it not deeply concerning that 12 to 17-year-old males have a 27 times greater-than-expected risk of developing myocarditis or pericarditis, and 18 to 24-year-old males have a 32 times greater risk of developing this life-threatening condition within a week of their second dose of one of these experimental COVID shots?  Does this not constitute a major red flag, warranting an immediate halt to these vaccinations and thorough investigation to prevent further harm to our teens and young adults? Do these risks not outweigh any possible benefits from Pfizer’s COVID shot in a population at statistically zero risk of dying from COVID illness?

We have also seen continued assurances from  our public health authorities that these experimental COVID vaccines are “…safe and effective,” and “…benefits of vaccination far outweigh any harm.” What are their assurances based upon? We have seen multiple VAERS reports of 12 to 17-year-olds who have suddenly died following one of these shots. Are the VAERS reports not proof of ultimate harm? What would the parents of these unfortunate young people — sadly, listed only as a VAERS ID number in these reports — say about their loss, and that of extended family and friends? With every passing day, injuries continue to be reported following these experimental vaccines, each with the potential to result in profound harm and loss — permanent disabilities and even untimely deaths. What on earth are our public health authorities waiting for?

Clearly, with these recommendations from our public health “experts”, it will be increasingly vital for parents to fully educate themselves, so they can make clear, informed decisions on what is in their children’s best interest.

***

This article contains a growing list of deaths and serious injuries that occurred after the experimental COVID vaccine was administered. The death and serious injury reports are culled from the CDC’s Vaccine Adverse Event Reporting System (VAERS) and the media. Although the deaths and serious injuries are temporally related to the COVID vaccination, Children’s Health Defense – California Chapter cannot claim the COVID vaccine definitively caused the deaths or serious injuries. That said, the symptom patterns and timing are highly suspicious, and tend to follow patterns of adverse events widely recognized to occur after other vaccinations. The death reports serve as anecdotes that may soon establish a pattern. Children’s Health Defense – California Chapter is providing regular updates on newly reported deaths that occur after COVID vaccination. As always, Children’s Health Defense – California Chapter supports fully informed consent and no medical mandates. This is not medical advice. Please share this information with, and consult your doctor